Integra LifeSciences Holdings is engaged in medical technology. Co.'s global reportable business segments include: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical segment focuses on the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Tissue Technologies segment has a regenerative platform that primarily addresses the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection. We show 57 historical shares outstanding datapoints in our coverage of IART's shares outstanding history.
Understanding the changing numbers of IART shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like IART versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching IART by allowing them to research IART shares outstanding history
as well as any other stock in our coverage universe. |
Free IART Email Alerts:
Video: Shares Outstanding Importance
